Physician profile

Patrick Neal Marcus

Interventional Cardiology · Kirkland, WA

NPI 1053706929

$26,850.28

in general payments reported to CMS, 2019-2025

42 companies · $142 in 2025

The $142 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).

Payments by year

General and research payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$8,588.94
Travel and Lodging$7,601.04
Grant$2,000.00
Education$239.57

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbott Laboratories $7,905.94 2021-2024 Supera, Optis, Perclose Proglide
Medtronic, INC. $4,377.80 2021-2025 Corevalve Evolut R, Onyx Frontier, Azure Xt Dr Mri Surescan
Edwards Lifesciences Corporation $2,801.94 2024 Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia
Abiomed $1,507.57 2020-2025
Penumbra, INC. $1,313.68 2024 Indigo System
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $1,018.81 2020-2024 Lifevest
Inari Medical, INC. $934.14 2021-2023 Flowtriever Catheter, S, Ct Thrombectomy System Kit
Actelion Pharmaceuticals US, INC. $789.83 2020-2024 Uptravi, Opsumit
W. L. Gore & Associates, INC. $660.03 2021-2024 Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Cardioform Septal Occluder
Astrazeneca Pharmaceuticals Lp $445.67 2020-2024 Wainua
Impulse Dynamics (USA) INC. $413.28 2022-2023 Optimizer
Astellas Pharma US INC $404.92 2020-2021
Pfizer INC. $377.40 2021-2024
Cardiovascular Systems INC. $373.11 2021-2022
Terumo Medical Corporation $342.29 2022-2024 Glidesheath Slender, Angio-Seal, Heartrail
Show all 42 companies
CompanyGeneral paymentsYearsTop products
Shockwave Medical, INC $324.08 2022-2024 Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter
Teleflex LLC $308.00 2021-2024 Trapliner
Boston Scientific Corporation $282.80 2023-2024 Ranger, Rotapro, Watchman Flx
Amgen INC. $245.97 2021-2024 Repatha
Philips North America LLC $229.01 2022-2023
Novartis Pharmaceuticals Corporation $192.81 2022-2024
Chiesi USA, INC. $156.13 2020-2022
Avinger INC. $143.00 2023 Pantheris
Angiodynamics, INC. $139.45 2022
Bard Peripheral Vascular, INC. $128.03 2023-2024 Crosser Iq, Venclose Maven Catheter
Esperion Therapeutics, INC. $125.00 2021
United Therapeutics Corporation $125.00 2021
Janssen Pharmaceuticals, INC $115.28 2021-2024 Xarelto
Sanofi-Aventis U.S. LLC $101.90 2022-2023
Genzyme Corporation $96.67 2021
Cardiva Medical, INC. $92.54 2023-2024 Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs
Saranas, INC. $88.24 2021
Medtronic Vascular, INC. $62.39 2020
Boehringer Ingelheim Pharmaceuticals, INC. $36.99 2023-2024 Jardiance
Cvrx, INC. $28.80 2024 Barostim Neo System
Lexicon Pharmaceuticals, INC. $27.35 2023 Inpefa
Bayer Healthcare Pharmaceuticals INC. $26.88 2022
Cordis US Corp. $24.38 2023 Outback Elite
Kestra Medical Technology Services, INC. $23.46 2025 Assure Wcd
Kiniksa Pharmaceuticals, Ltd. $22.26 2023 Arcalyst
Medline Industries Lp $18.95 2024 Medline Industries, INC.
Contego Medical, INC $18.50 2024

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

Research and ownership

$149.16 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Patrick Neal Marcus

$26,850.28

in general payments reported 2019-2025

Years
2020-2025
Top company
Abbott Laboratories
Context
The $142 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).

https://glasscript.com/doctor/5599721/patrick-neal-marcus

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.